A New Jersey state jury on Wednesday slammed Johnson & Johnson and its talc supplier with combined punitive damages of $80 million after finding that the pharmaceutical giant acted with reckless indifference in selling asbestos-containing talcum powder that contributed to a man’s development of mesothelioma.
A BladeRoom executive conceded under cross-examination from Emerson Electric Co.’s attorney in BladeRoom Group Ltd’s trade secrets suit over a $200 million Facebook data center Tuesday that his company had never sold the technology it pitched to Facebook for a data center Emerson Electric Co. eventually built.
Counsel for Johnson & Johnson urged a New Jersey state jury Tuesday not to award punitive damages over claims the pharmaceutical giant sold asbestos-containing talcum powder that contributed to a man’s developing mesothelioma, saying there was no “smoking gun” evidence that company officials recklessly sold products they knew would likely cause harm.
A manager of the largest investor in semiconductor company PLX Technology Inc. testified on Tuesday in a suit brought by shareholders over a sale that allegedly undervalued the company that he thought PLX was in poor shape and in danger of failing at the time of his investment.
Convicted pharmaceutical executive Martin Shkreli owes an investor who put $200,000 into Shkreli's hedge fund nearly twice that amount since the investor lost money on a real estate deal while his cash was tied up, a Brooklyn federal judge ruled Monday.
Wilmington Trust Corp.’s outside auditor curbed its reliance on the bank’s internal audit section in 2009 as concern about the reliability of the bank’s past-due loan reporting mounted, a KPMG LLP manager testified Tuesday during a federal criminal trial in Delaware for four bank executives.
The federal judiciary's Advisory Committee on Civil Rules on Tuesday approved rule changes designed to quell discovery disputes and time-wasting over depositions of corporate representatives.
A California federal jury found that Romeo and Juliette Inc. willfully infringed design patents covering boots held by Ugg maker Deckers Outdoor Corp., awarding a $5.2 million verdict — an amount that lawyers say could change based on the willfulness finding and a pending estoppel defense.
An Eastern District of Texas jury decided Tuesday that Apple Inc. infringed four VirnetX network security patents and ordered the tech giant to pay $502.6 million in damages, the latest nine-figure verdict in the long-running dispute.
The U.S. Department of Justice recalled AT&T’s chief content officer to the stand Tuesday in D.C. federal court to confront him with another damaging communication against the AT&T-Time Warner merger, this time in which he discussed pay-TV distributors banding together against a content provider.
The U.S. Justice Department has come to the aid of a former State Street executive charged with securities fraud who was struggling to get evidence from the overseas clients he allegedly swindled, a prosecutor said Tuesday in a show of sportsmanship two months before the case is scheduled for trial in Boston.
A Manhattan jury on Tuesday convicted English lawyer Michael Little of 19 criminal counts, finding him guilty of helping the children of deceased investor Harry Seggerman avoid paying tax on $14 million of inheritance money and of dodging his own taxes.
The U.S. Department of Justice did not meet a Friday deadline to ask the U.S. Supreme Court to review a Second Circuit decision dismissing the convictions of two former Rabobank traders over constitutional concerns stemming from the use of testimony compelled overseas.
Members of the Pennsylvania Supreme Court appeared skeptical during oral arguments on Tuesday that a jury’s notes on a verdict slip gave Giant Eagle Inc. grounds to attack a $2.1 million damage award won by the victim of a shooting outside one of the supermarket chain’s stores.
Prosecutors on Monday sought to get a last-minute interview with a former British banking group official in a case against two ex-Deutsche Bank traders accused of rigging the London Interbank Offered Rate after a Manhattan federal judge suggested the case may hinge on such evidence.
A Massachusetts federal judge said Tuesday she won’t deviate from common court practices to prematurely unseal details about Harvard University’s admissions process in a discrimination suit concerning Asian-American applicants that the U.S. Department of Justice wanted to see while it considers taking a stance in the dispute.
The National Collegiate Athletic Association asked a California federal court on Friday to postpone a December trial over whether its restrictions on student-athlete compensation are anti-competitive, saying a key defense attorney has scheduling conflicts.
A Texas state jury sentenced a San Antonio attorney to 80 years in prison for pressuring clients to have sex with him in exchange for legal services, a Bexar County district attorney spokesperson told Law360 on Monday.
Prosecutors told jurors during closing arguments on Monday in the fraud trial of ex-U.S. Rep. Stephen Stockman, R-Texas, that they had been presented with overwhelming evidence of his guilt in what the government said was a scheme to solicit money under the guise of using it for charity when it actually paid personal and campaign expenses.
A California attorney convicted of helping two stockbrokers conduct a pump-and-dump scheme cannot redo his 2016 trial in light of potential violations of a plea agreement since revealed about the co-conspirator who flipped on him, a Massachusetts federal judge ruled in court Monday.
There's no reason for limiting unbundled legal services to family law or even pro se litigants. Wider adoption, especially by litigators, presents an opportunity to correct law's distribution and pricing problem, to make justice practically available to all, and to dethrone litigation as the "sport of kings," says New York-based trial lawyer David Wallace.
The Pennsylvania Superior Court recently ruled that the Fair Share Act applies to asbestos litigation, meaning that defendants are only responsible for the percentage they are found liable for. Defendants in such cases should ensure that all possibly liable defendants are timely joined as parties in the lawsuit, says Theresa Mullineaux of Husch Blackwell LLP.
Trial consultants Bliss Piverger and Christina Marinakis of Litigation Insights Inc. discuss how jurors’ feelings about safety in the wake of a mass shooting can influence their views on lawsuits against premises owners, security companies, event organizers, gun manufacturers and social media platforms.
Like medical professionals, lawyers often resist policies to reduce errors due to the culture of perfectionism that permeates the industry. Autonomy is key to the legal professional's prestige and the outward demonstration of competence is key to maintaining autonomy, says Peter Norman of Winnieware LLC.
Many bad drug and device law decisions lately have come from appellate courts, with the Eleventh Circuit in particular creating obstacle courses for both defense practitioners and judges. This month's Rowe v. Mentor Worldwide LLC ruling is an example. All the claims would have been dismissed if not for a pesky, unsound and inconsistent Eleventh Circuit case, says Stephen McConnell of Reed Smith LLP.
It is undisputed that in his first year in office President Trump was able to confirm a significant number of judges to the federal bench. How it happened — and whether it's a good thing — are debated here by Sen. Chuck Grassley, R-Iowa, and Sen. Dianne Feinstein, D-Calif.
The recent Third Circuit opinion in Shuker v. Smith & Nephew got the most important issue right — when you have a multicomponent medical device, premarket approval preemption is to be addressed on a component-by-component basis. This is an important question, because surgeons engaging in off-label use do mix and match parts with different regulatory backgrounds, says Michelle Yeary of Dechert LLP.
Not all demonstratives are created equal. While lawyers as a group have mastered the art of presenting arguments orally and in writing, there is much room for improvement in how we present arguments visually, says Jason Fowler of Covington & Burling LLP.
In the final article in this five-part series, longtime trial lawyer David Dolkas discusses Level One and Level Two investigative questioning.
The U.S. Supreme Court may soon revisit a seminal decision on products liability law for pharmaceutical manufacturers. If the court grants Merck & Co.'s request for certiorari in Fosamax, it could signal that lower courts, as well as branded manufacturers, will finally receive guidance on Levine’s "clear evidence" standard, say attorneys with Morrison & Foerster LLP.